Reported Tuberculosis in the United States, 2020

Return to Main Menu

Table 48. Tuberculosis Cases and Percentages, by Directly Observed Therapy (DOT): Reporting Areas, 20181

See Surveillance Slides #51 and #52.

Table 48. Tuberculosis Cases and Percentages, by Directly Observed Therapy (DOT): Reporting Areas, 2017
Reporting Area Total Cases Cases with Initial Drug Regimen Prescribed2 Cases with Information on Directly Observed Therapy Percentage of Cases by Directly Observed Therapy3
No. (%) DOT Only Both DOT and Self-Administered
United States 9,006 8,738 8,578 (98.2) (61.3) (33.7)
Alabama 91 89 88 (98.9) (44.3) (55.7)
Alaska 63 61 59 (96.7) (96.6) (3.4)
Arizona 178 176 176 (100.0) (84.7) (14.8)
Arkansas 76 72 68 (94.4) (91.2) (7.4)
California 2,097 2,034 2,012 (98.9) (46.9) (48.2)
Colorado 64 63 63 (100.0) (81.0) (7.9)
Connecticut 51 50 50 (100.0) (8.0) (86.0)
Delaware 22 21 19 (90.5) (47.4) (52.6)
District of Columbia 36 33 33 (100.0) (84.8) (0.0)
Florida 591 577 573 (99.3) (14.1) (84.8)
Georgia 270 258 255 (98.8) (82.4) (16.5)
Hawaii 120 117 115 (98.3) (96.5) (1.7)
Idaho 15 13 13 (100.0) (23.1) (53.8)
Illinois 319 311 311 (100.0) (63.7) (30.2)
Indiana 116 113 113 (100.0) (73.5) (26.5)
Iowa 49 46 46 (100.0) (82.6) (17.4)
Kansas 28 28 20 (71.4) (85.0) (15.0)
Kentucky 65 60 60 (100.0) (98.3) (1.7)
Louisiana 105 103 103 (100.0) (58.3) (20.4)
Maine 14 14 13 (92.9) (46.2) (46.2)
Maryland 208 203 199 (98.0) (66.3) (33.7)
Massachusetts 200 194 173 (89.2) (71.7) (20.8)
Michigan 108 105 101 (96.2) (88.1) (11.9)
Minnesota 172 170 169 (99.4) (36.1) (62.7)
Mississippi 80 72 71 (98.6) (63.4) (36.6)
Missouri 80 76 68 (89.5) (22.1) (76.5)
Montana 5 5 5 (100.0) (0.0) (100.0)
Nebraska 27 27 23 (85.2) (4.3) (87.0)
Nevada 69 67 67 (100.0) (34.3) (65.7)
New Hampshire 12 12 12 (100.0) (75.0) (25.0)
New Jersey 291 285 283 (99.3) (55.1) (27.9)
New Mexico 39 39 39 (100.0) (94.9) (5.1)
New York State4 191 189 186 (98.4) (18.8) (76.3)
New York City 553 539 497 (92.2) (56.7) (17.9)
North Carolina 196 191 190 (99.5) (95.3) (4.7)
North Dakota 13 13 13 (100.0) (84.6) (15.4)
Ohio 178 173 173 (100.0) (80.9) (12.7)
Oklahoma 74 70 70 (100.0) (14.3) (84.3)
Oregon 81 80 80 (100.0) (92.5) (6.3)
Pennsylvania 213 204 204 (100.0) (74.5) (25.0)
Rhode Island 20 20 20 (100.0) (10.0) (90.0)
South Carolina 86 82 82 (100.0) (63.4) (35.4)
South Dakota 12 11 11 (100.0) (36.4) (63.6)
Tennessee 139 133 133 (100.0) (97.7) (2.3)
Texas 1,116 1,079 1,061 (98.3) (87.5) (11.3)
Utah 18 18 18 (100.0) (83.3) (16.7)
Vermont 5 5 4 (80.0) (0.0) (75.0)
Virginia 204 199 198 (99.5) (89.4) (9.6)
Washington 190 185 185 (100.0) (63.8) (20.5)
West Virginia 6 6 6 (100.0) (83.3) (16.7)
Wisconsin 49 46 46 (100.0) (82.6) (17.4)
Wyoming 1 1 1 (100.0) (0.0) (100.0)
American Samoa5 2 2 0 (0.0)
Fed. States of Micronesia5 104 104 102 (98.1) (88.2) (9.8)
Guam5 71 68 68 (100.0) (7.4) (92.6)
Marshall Islands5 367 360 253 (70.3) (17.8) (81.8)
Northern Mariana Islands5 47 47 46 (97.9) (54.3) (45.7)
Puerto Rico5 28 27 27 (100.0) (59.3) (0.0)
Palau5 17 15 14 (93.3) (28.6) (71.4)
U.S. Virgin Islands5 1 1 1 (100.0) (0.0) (100.0)

1Most recent year for which data are available.
2Includes persons alive at diagnosis with an initial drug regimen of one or more drugs prescribed.
3Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia).
4Excludes New York City.
5Not included in U.S. totals.
Ellipses (…) indicate that the percentage cannot be calculated, and the denominator is 0.